KL and colorectal carcinoma: Ultimately, these approaches should be evaluated in animal models of CRC to determine whether (i) enhanced klotho expression suppresses Wnt activity in intestinal neoplasia and thus reduces tumour burden, and (ii) the reduced Wnt activity resulting from klotho expression interferes with the chemopreventive action of butyrate.